Welcome!

News Feed Item

Biotech Investors and Leaders to Headline 10th Annual Biotech Showcase™ 2018

The 10th annual Biotech Showcase™, the largest international biotech investor conference in the world produced by Demy-Colton and EBD Group, will bring together over 3,500 life science decision makers and investors from 50+ countries to collaborate and discuss industry trends through panels, workshops, and fireside chats. Taking place on January 8-10, 2018 at the Hilton San Francisco Union Square, attendees will hear from key biotech investors, leaders, pharma executives, and other industry advisors on topics such as the future of biotech and the public markets, the rapidly advancing digital and medical technologies, and the health of cross-border investments and collaboration in China.

“We’re looking forward to participating in Biotech Showcase, which continues to serve as a home base for the life science community to discuss innovative opportunities and investment partnering during the largest week in healthcare in San Francisco,” said Art Pappas, Managing Partner, Pappas Capital.

Understanding the health of the life sciences and biotech industries involves dissecting the past year’s successes. The January 10th lunch plenary, “Reflecting on 2017 record-breaking venture numbers: What’s behind the surge?”, will be moderated by Ellen Corenswet, Partner, Covington & Burling LLP, and include perspectives from investors and healthcare companies on 2017 financials:

  • Han Lee – Senior Director, Corporate Development, AstraZeneca
  • Marian Nakada – VP, Venture Investments, Johnson & Johnson Innovation
  • Jonathan Norris – Managing Director, Healthcare Practice, Silicon Valley Bank
  • Art Pappas – Managing Partner, Pappas Ventures
  • Alex Zisson – Managing Director, H.I.G. Capital

The January 8th lunch plenary, “The future of biotechnology and life sciences sector: Are we at a tipping point?”, will discuss whether the pace of heavy investments and accelerated drug approval in 2017 will continue. The session will be moderated by Sara Radcliffe, President and CEO, California Life Sciences Association, and include panelists:

  • Ron Cohen – President and CEO, Acorda Therapeutics, Inc.
  • Joaquin Duato – Executive VP and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson; Chairman of the Board, PhRMA
  • Jim Greenwood – President and CEO, Biotechnology Innovation Organization
  • Rachel King – CEO, GlycoMimetics, Inc.
  • Paul Mignon – President and Global Head, inVentiv Health Selling Solutions, INC Research/inVentiv Health

“I’m looking forward to discussing the promising projections for next year at Biotech Showcase and uncovering with investors and industry decision makers where the biggest growth and investment opportunities are as we move into 2018,” said Asthika Goonewardene, Senior Biotech Analyst, Bloomberg Intelligence, who is leading a January 8th workshop, “The public markets and biotech: What to expect in 2018.” Gabriel Cavazos, Director, Investment Banking, Leerink Partners LLC will also participate in this workshop moderated by Barbara Ryan, Founder, Barbara Ryan Advisors.

The program will include a Digital Medicine & Medtech Showcase, highlighting the companies and partnerships that are making the advancement of digital medicine possible, such as Qualcomm Life and Digital Therapeutics Alliance, among others. “We’re looking forward to diving into conversations with our colleagues on the future of medical technologies and the challenges we are working to overcome as leaders driving change in healthcare through digital medicine,” said Rick Valencia, President, Qualcomm Life.

A January 10th closing panel, “The future of healthcare with the convergence of digital innovations” moderated by Anne Smart, Managing Director, ClearView Healthcare Partners, will elaborate on this topic with panelists from organizations working to drive technological advancements in life sciences:

  • Megan Coder – Executive Director, Digital Therapeutics Alliance
  • Mary Lou Jepsen – Founder and CEO, Openwater
  • Aaron Nelson – General Partner, dRx Capital; Principal, Novartis Venture Fund
  • Joanna Schulman – CEO, AIDIA
  • Rick Valencia – President, Qualcomm Life

The list of current speakers can be found on the Biotech Showcase Speaker page here and the Digital Medicine & Medtech Showcase Speaker page here. A concurrent event, China Showcase, will highlight cross-border investment and collaboration opportunities through key sessions, keynotes, and valuable networking opportunities.

For more information or to register for the event, go to BiotechShowcase.com. Credentialed press can apply for free registration online here. Follow Biotech Showcase on Twitter: @EBDGroup and @DemyColton (hashtag: #BTS18).

About Demy-Colton

Since 2008, Demy-Colton has been at the forefront of building networks between leaders from innovative biotech companies and industry stakeholders to examine and address biotech opportunities and challenges and deliver on the promise of transformational science.

We do this through facilitating networking and biotech community development on an international scale. Our investor conferences and CEO Summits expand communities that transcend geographical boundaries establishing ongoing, high-value relationships that contributes greatly to the evolution of the biopharmaceutical ecosystems we cultivate.

We set a unique stage where biotech leaders, investors, and stakeholders can connect to realize significant opportunities for investment, learning, and growth. Our events spur introductions and thoughtful conversations. In turn, inspiration, ideas, and opportunities for investment flow. Demy-Colton’s expanding portfolio of conferences includes:

  • Biotech Showcase™ – a unique forum in San Francisco for presenting to investors and business development executives
  • Digital Medicine & MedTech Showcase™ – A two and a half day meeting, coinciding with Biotech Showcase, where key opinion leaders, investors and CEOs in the digital medicine and medtech spaces examine the latest industry advances and trends.
  • China Showcase A one-day meeting, coinciding with Biotech Showcase, that highlights cross-border biotech investment and collaboration opportunities between China and the U.S.
  • Biotech CEO Summit™ – An invitation-only, thought-provoking meeting for biotech industry leaders united by the common goal of driving responsible growth and innovation
  • Biotech CEO Summit Europe™ – An invitation-only, one-of-a-kind event dedicated to helping the leadership of newly public and late stage private biotech companies navigate the constantly evolving biotech landscape

About EBD Group

EBD Group's overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our seven landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE®, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings.

Today our events (BIO-Europe®, BIO-Europe Spring®, BioPharm America™, Biotech Showcase™, ChinaBio® Partnering Forum, Cell & Gene Exchange, and BioEquity Europe) annually attract more than 12,000 senior life science executives who engage in over 48,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry.

Tune into EBD Group’s Partnering Insight for timely coverage of news that influences the business strategies of the life science industry. EBD Group is an Informa company. For more information please visit www.ebdgroup.com.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In his keynote at 19th Cloud Expo, Sheng Liang, co-founder and CEO of Rancher Labs, discussed the technological advances and new business opportunities created by the rapid adoption of containers. With the success of Amazon Web Services (AWS) and various open source technologies used to build private clouds, cloud computing has become an essential component of IT strategy. However, users continue to face challenges in implementing clouds, as older technologies evolve and newer ones like Docker c...
HyperConvergence came to market with the objective of being simple, flexible and to help drive down operating expenses. It reduced the footprint by bundling the compute/storage/network into one box. This brought a new set of challenges as the HyperConverged vendors are very focused on their own proprietary building blocks. If you want to scale in a certain way, let's say you identified a need for more storage and want to add a device that is not sold by the HyperConverged vendor, forget about it...
"MobiDev is a software development company and we do complex, custom software development for everybody from entrepreneurs to large enterprises," explained Alan Winters, U.S. Head of Business Development at MobiDev, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
22nd International Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, and co-located with the 1st DXWorld Expo will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud ...
The next XaaS is CICDaaS. Why? Because CICD saves developers a huge amount of time. CD is an especially great option for projects that require multiple and frequent contributions to be integrated. But… securing CICD best practices is an emerging, essential, yet little understood practice for DevOps teams and their Cloud Service Providers. The only way to get CICD to work in a highly secure environment takes collaboration, patience and persistence. Building CICD in the cloud requires rigorous ar...
@DevOpsSummit at Cloud Expo, taking place November 12-13 in New York City, NY, is co-located with 22nd international CloudEXPO | first international DXWorldEXPO and will feature technical sessions from a rock star conference faculty and the leading industry players in the world.
"We're focused on how to get some of the attributes that you would expect from an Amazon, Azure, Google, and doing that on-prem. We believe today that you can actually get those types of things done with certain architectures available in the market today," explained Steve Conner, VP of Sales at Cloudistics, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Sanjeev Sharma Joins November 11-13, 2018 @DevOpsSummit at @CloudEXPO New York Faculty. Sanjeev Sharma is an internationally known DevOps and Cloud Transformation thought leader, technology executive, and author. Sanjeev's industry experience includes tenures as CTO, Technical Sales leader, and Cloud Architect leader. As an IBM Distinguished Engineer, Sanjeev is recognized at the highest levels of IBM's core of technical leaders.
As Cybric's Chief Technology Officer, Mike D. Kail is responsible for the strategic vision and technical direction of the platform. Prior to founding Cybric, Mike was Yahoo's CIO and SVP of Infrastructure, where he led the IT and Data Center functions for the company. He has more than 24 years of IT Operations experience with a focus on highly-scalable architectures.
JETRO showcased Japan Digital Transformation Pavilion at SYS-CON's 21st International Cloud Expo® at the Santa Clara Convention Center in Santa Clara, CA. The Japan External Trade Organization (JETRO) is a non-profit organization that provides business support services to companies expanding to Japan. With the support of JETRO's dedicated staff, clients can incorporate their business; receive visa, immigration, and HR support; find dedicated office space; identify local government subsidies; get...
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
Dion Hinchcliffe is an internationally recognized digital expert, bestselling book author, frequent keynote speaker, analyst, futurist, and transformation expert based in Washington, DC. He is currently Chief Strategy Officer at the industry-leading digital strategy and online community solutions firm, 7Summits.
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
DXWorldEXPO LLC announced today that Dez Blanchfield joined the faculty of CloudEXPO's "10-Year Anniversary Event" which will take place on November 11-13, 2018 in New York City. Dez is a strategic leader in business and digital transformation with 25 years of experience in the IT and telecommunications industries developing strategies and implementing business initiatives. He has a breadth of expertise spanning technologies such as cloud computing, big data and analytics, cognitive computing, m...
As DevOps methodologies expand their reach across the enterprise, organizations face the daunting challenge of adapting related cloud strategies to ensure optimal alignment, from managing complexity to ensuring proper governance. How can culture, automation, legacy apps and even budget be reexamined to enable this ongoing shift within the modern software factory?